Access

Correspondence

Nature Reviews Drug Discovery 7, 710 (1 August 2008) | doi:10.1038/nrd2466-c2

Downsides to the nitrate|[ndash]|nitrite|[ndash]|nitric oxide pathway in physiology and therapeutics? Reply from Lundberg, Weitzberg and Gladwin

Jon O. Lundberg , Eddie Weitzberg & Mark T. Gladwin

We appreciate the comments relating to our Review article (The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nature Rev.